Consultant

Prof Dae Kim

Consultant ENT & Head and Neck/Thyroid Surgeon
MBChB, BDS, MSc, FRCS Orl-HNS, PhD
Professional Image of Prof Dae Kim

Professor Dae Kim is a Consultant Ear, Nose and Throat (ENT) and Thyroid Surgeon with a particular interest in minimally-invasive 'scarless' Robotic and Endoscopic thyroid surgery.

Ear, nose and throat, Thyroid
English, Korean
In-person, Phone call, Video call
New £300 (follow-up £250)

Bio

Professor Dae Kim is a Consultant ENT and Thyroid Surgeon at The London Clinic.

He has a clinical interest in minimally-invasive 'scarless' Robotic and Endoscopic thyroid surgery. He completed a dedicated 'Robotic and Endoscopic Thyroid Surgery Fellowship' at the prestigious Severance Robotic Institute (Seoul) for transaxillary 'scarless' robotic thyroidectomy.  

Working closely with oncologists, thoracic surgery and vascular surgery colleagues, he is developing UK’s leading Neo-adjuvant Surgery Service for advanced thyroid cancer patients to achieve improved survival.

Professor Kim is an academic ‘surgeon-scientist’, and after research training at Harvard University and Birmingham University he was awarded a PhD doctorate and the prestigious 'Syme Medal' by the Royal College of Surgeons. He is Hon. Faculty at the Institute of Cancer Research, London, where he continues molecular and genomic research in advanced thyroid cancer.

More information

The London Clinic Consulting Rooms

5 Devonshire Place

London W1G 6HL

  • Year qualified 1995
  • Edinburgh University, UK. MB ChB: Medical Degree 1990-1995
  • The Open University, UK. MSc (Distinction Award) 1997-1999
  • Birmingham University, UK. BDS: Dental degree 1997-2001
  • MRCS: Membership of The Royal College of Surgeons of Edinburgh, UK 2002
  • Birmingham University, UK. PhD: Institute of Biomedical Research 2002-2005
  • FRCS (ORL-HNS): CCT in Otolaryngology & Fellowship of the Royal College of Surgeons, UK 2009
  • Consultant ENT & Head and Neck/Thyroid Surgeon
    The London Clinic
  • Consultant Head & Neck and Thyroid Surgeon 
    The Royal Marsden Hospital, London
  • Hon. Faculty 
    Institute of Cancer Research, London
  • Research Grant Awards over £4 million: Chief Investigator for HoT (NIHR HTA funded) multi-centre trial.
  • National Institute of Health Research (NIHR) Head & Neck Cancer CSG Subgroup Committee Member:
  • Royal Society of Medicine (Laryngology & Rhinology) – Council Member (2018-2028)
  • Asia-Pacific Society of Thyroid Surgery: Scientific Committee

Awards

  • The British Journal of Surgery Prize: BRAF V600 co-testing in thyroid FNA cytology: short-term experience in a large cancer centre in the UK. British Association of Endocrine & Thyroid Surgeons: Awarded for best research paper and presentation. (2014)
  • University College London & Sethia Chitra Medal for Education & Innovation 2013: 1st Annual Course in Robotic and Minimally-invasive ENT/Head & Neck Surgery, UCLH, London.
  • The Winston Churchill Trust award: 2012 Churchill Fellow - Training in Robotic & Endoscopic thyroid and neck surgery with Professor Chung, Minimally Invasive & Robotic Surgery Institute, Yonsei University, Seoul, Korea (2012).

  • The Syme Medal for Research: Royal College of Surgeons of Edinburgh: Awarded by Thesis submission for best research leading to a higher degree. (2008)

  • The British Journal of Surgery Prize: Securin induces genetic instability in thyroid cancer by inhibiting double-stranded DNA repair activity. British Association of Endocrine & Thyroid Surgeons: Awarded for best research paper and presentation. (2008)

  • HCA International Foundation Training Scholarship Award: Da Vinci robotic & Endoscopic training in Head & Neck Surgery (2012)

  • W Yang, S Rogers, D Kim. Challenges of Shared Decision-making in Thyroid Cancer: A systematic review and meta-ethnography. Accepted: JAMA Otolaryngology Head & Neck Surgery Jan 2023
  • Jason C. Fleming, Jeongmin Woo, Karwan Moutasim, Christopher J. Hanley, Steven J. Frampton, Oliver Wood, Matthew Ward, Christopher H. Woelk, Christian H. Ottensmeier, Sassan Hafizi, Dae Kim and Gareth J. Thomas. CTEN Induces Tumour Cell Invasion and Survival and Is Prognostic in Radiotherapy-Treated Head and Neck Cancer. Cancers (Basel) 2020 Oct 13;12(10)
  • Allin DM, Shaikh R, Carter P, Thway K, Sharabiani MTA, Gonzales-de-Castro D, O'Leary B, Garcia-Murillas I, Bhide S, Hubank M, Harrington K, Kim D, Newbold K. Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer. Eur J Cancer. 2018 Nov;103:165-175.
Share

Contact us

Request an appointment with our world-leading consultants today, or speak to our helpful advisors for tailored advice.